Rejection

(redirected from Antibody-Mediated Rejection)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms.

rejection

[ri′jek·shən]
(immunology)
Destruction of a graft by the immune system of the recipient.

What does it mean when you dream about a rejection?

Rejection in a dream may suggest that there are feelings or situations the dreamer wants to be rid of.

References in periodicals archive ?
Speaking about the study, senior author Daniel Kreisel said, "Antibody-mediated rejection is a vexing problem that is increasingly being acknowledged as an important cause of lung failure after transplantation."
Older kidney transplant patients experience less antibody-mediated rejection: A retrospective study of patients with mild to moderate sensitization.
Antibody-mediated rejection (ABMR) was defined when there was (1) histological evidence of tissue injury, (2) C4d positivity, and (3) the detection of circulating anti-HLA donor-specific antibodies.
Abbreviations ABMR: Antibody-mediated rejection eGFR: Estimated glomerular filtration rate OPSI syndrome: Overwhelming postsplenectomy infection syndrome IVIG: Intravenous immunoglobulins.
Singer et al., "The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection," American Journal of Transplantation, vol.
Pre- and post-operative plasmapheresis results in a dramatic drop in DSA levels, which reduces the risk of hyper-acute rejections and early antibody-mediated rejections. Intravenous immunoglobulins will neutralise DSA for weeks.
Six patients lost their grafts because of allograft dysfunction, in three of whom acute antibody-mediated rejection (N = 2) and thrombosis of allograft vein were confirmed histologically.
Pathologists and other clinicians from Europe discuss antibody-mediated rejection of organ allografts, the maternal death autopsy, the classification and treatment of non-small-cell lung carcinoma, the pathology of obesity, the role of the histopathologist in stratified medicine for cancer, the mucosal pathology of the gastric cardia and Barrett's esophagus, the pathology of regenerative and neoplastic hepatocellular nodules, serrated lesions of the colon and rectum, the pathology of chronic inflammatory bowel disease, the diagnosis and therapy for gastrointestinal MALT (mucosa-associated lymphoid tissue) lymphoma, medical revalidation for histopathologists in the UK, molecular testing for human papillomavirus, and the role of tensins in health and disease.
(9) Most allograft damage is mediated though the activation of complement; C4d deposition is widely accepted as a marker for antibody-mediated rejection in renal allografts.
Antibody-mediated rejection is a type of rejection that occurs when a patient has antibodies circulating in their blood against the donor organ (i.e.

Full browser ?